Minghao Zheng

Professor Minghao Zheng is a Winthrop Professor of Orthopaedic Research at The University of Western Australia (UWA), School of Biomedical Sciences. He holds dual roles as a researcher and co-founder of Orthocell Limited (ASX:OCC), a biomedical company. His expertise spans bone biology, regenerative medicine, and cell therapy, with pioneering work in collagen scaffolds for cartilage and tendon repair. He developed MACI (Matrix-induced Autologous Chondrocyte Implantation) and ATT (Autologous Tenocyte Therapy), and his research on Giant Cell Tumour of Bone is WHO-recognized.

• Education: MB BS (Shantou University), PhD (UWA, 1993), Doctor of Medicine (UWA, 2000)
• Affiliations: Fellow of Royal Colleges of Pathologists (UK/Australasia), Associate Editor of Stem Cell Research and Therapy

Research focuses on osteoclast biology, cellular therapies in orthopaedics, and tissue engineering. His work addresses bone and joint regeneration, with 250+ publications and 8 international patents. Key contributions include bioreactor development for mechanical tissues and validation of human bone allografts.

His recent studies emphasize peripheral nerve repair via electrical/magnetic stimulation and mitochondrial transfer protocols. Grants include projects on pearl-based bone substitutes and bio-textile ligament replacements.

• Awards: 2022 Vice-Chancellor’s Award for HDR Supervision
• Grants/Projects: 76+ active/finished projects, including antibiotic-laden bone substitutes and ACL reconstruction innovations